Observational study on effect of lock down due to COVID 19 on HBA1c levels in patients with diabetes: Experience from Central India

COVID-19 pandemic: Effects of national lockdown on the state of health of patients with type 2 diabetes mellitus in a Moroccan population

“…Concerning HbA1c, our findings highlight a significant increment in both sexes after the lockdown period, in congruence with previous studies [ 13 , 16 , 31 , 35 ]. This increment can be associated with both the duration of the lockdown, weight gain, and the deterioration in glycemic control [ 31 , 34 , 36 , 37 ].…”

“…Indeed, significant deteriorations in both anthropometric and biochemical parameters have been observed after the lockdown. In congruence with previous studies, our patients have shown a tendency to gain weight and to increase their BMI after the lockdown [ 13 , 16 , 28 , 29 ]. However, only women showed a statistically significant increment in weight, which is known to be influenced by diet behaviors and physical activity [ 30 ].…”

“…Despite the high prevalence of T2DM in Morocco, data on the lockdown effects are still lacking, while in other countries, studies underlined that the discontinuation of surveillance during the lockdown period has negatively affected patients with T2DM [ [13] , [14] , [15] , [16] , [17] ].…”

Effects of the COVID-19 lockdown on primary health care for persons with type 2 diabetes – Results from the German Disease Analyzer database

“…Only few studies on this topic were done in Europe, and to our knowledge, there is no study on management of diabetes during the lockdown in Germany [14][15][16][17][18][19]. Several studies demonstrated an improvement or no deterioration of glycemic control [5,12,13,15,16,17,19], whereas others showed poorer glycemic control after the lockdown [8][9][10][11]14,18]. The same applies to studies on weight change.…”

“…Recently, Selvin and Juraschek discussed perspectives of diabetes epidemiology in the COVID-19 pandemic, and they identified five diabetes-related research questions, one of which concerns the implications of the pandemic on prevention and management of diabetes [4]. So far, most studies on the effects of COVID-19 lockdown on metabolic control in persons with type 2 diabetes had rather small sample sizes, and were often carried out in non-European countries, especially in India [5][6][7][8][9][10][11][12][13]. Results from India, Saudi-Arabia and Turkey may not be generalizable to Western European countries due to cultural differences of lifestyles and the enormous differences in the health care systems.…”